---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-24-116698"
form_type: "8-K"
ticker: "PYXS"
cik: "0001782223"
company_name: "Pyxis Oncology, Inc."
filed_at: "2024-10-23T23:59:59+00:00"
generated_at: "2026-05-30T11:08:20.950513+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.4
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# Pyxis Oncology shareholders approve 5.5M share increase in equity plan at special meeting

## Summary
- Shareholders voted 23,234,250 to 12,829,636 to approve amendment to 2021 Equity and Incentive Plan adding 5,500,000 shares.
- Proposal to adjourn if needed passed but was unnecessary; quorum of 36,189,305 shares present.
- 59,422,945 shares outstanding; special meeting held virtually on October 23, 2024.

## SEC filing metadata
- accession: 0000950170-24-116698
- form_type: 8-K
- ticker: PYXS
- cik: 0001782223
- company_name: Pyxis Oncology, Inc.
- filed_at: 2024-10-23T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.4
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.07, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1782223/000095017024116698/0000950170-24-116698-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1782223/000095017024116698/pyxs-20241023.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-24-116698
- JSON: https://secwatch.observer/filing/0000950170-24-116698.json
- Plain text: https://secwatch.observer/filing/0000950170-24-116698.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.